Channels - The Favorable Short‐Term Efficacy of Preexisting COPD for Extensive‐Stage Small‐Cell Lung Cancer Receiving Immunotherapy :: FRELIP Discovery

Similar Items: The Favorable Short‐Term Efficacy of Preexisting COPD for Extensive‐Stage Small‐Cell Lung Cancer Receiving Immunotherapy

Quick Look
Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors
Quick Look
The tumor necrosis factor receptor superfamily in lung cancer immunotherapy: Therapeutic opportunities and challenges
Quick Look
Surgical Invasiveness Trumps Chronological Age: Determinants of Short‐Term Recovery in Octogenarian Lung Cancer Patients
Quick Look
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study
Quick Look
Revised tumor burden score for prognostic stratification in metastatic colorectal cancer patients receiving immunotherapy: a retrospective study
Quick Look
Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy
Quick Look
Lobe‐Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non‐Small Cell Lung Cancer: A Propensity Score‐Matched Analysis Based on the 8th Edition of the TNM Stage Classification
Quick Look
Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
Quick Look
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non‐Squamous Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study
Quick Look
Navigating the Evolution of Urothelial Carcinoma Treatment: From Chemotherapy to Immunotherapy
Quick Look
Clinicopathological and Prognostic Disparities in Part‐Solid Versus Pure Solid Pulmonary Nodules as Early‐Stage Lung Adenocarcinoma
Quick Look
First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307
Quick Look
Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance
Quick Look
Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator‐Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study
Quick Look
Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review
Quick Look
Harnessing Gut Microbiota to Enhance Immunotherapy in NSCLC: From Mechanisms to Translational Applications
Quick Look
Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer
Quick Look
The Long‐Term Quality of Life Study for Patients Received Chest Wall Reconstruction by Using 3D‐Printed PEEK Implants
Quick Look
Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside
Quick Look
Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancer
Quick Look
BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma
Quick Look
Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis
Quick Look
Molecular‐Based Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage Lung Cancer: A Systematic Review and Meta‐Analysis
Quick Look
The Impact of Immunotherapy on Hair Repigmentation in Patients With Thoracic Tumors: A Clinical Observation Based on Trichoscopy